AFMD (affimed.com) Sof foyda

AFMD (affimed.com) - kompaniyaning tovar belgisi

AI antitanalar skriningi bilan bog'liq yuqori xarajatlar moliyaviy bosimni keltirib chiqarmoqda, bu esa Affimed (AFMD) kompaniyasining joriy daromadlarida yaqqol ko'rinmoqda. 0.00 belgisi ushbu metrikaning joriy holatini ko'rsatadi. Xodimlarning sonini kamaytiradigan robotlashtirilgan molekulyar sintez ushbu xatarlarni yumshatadi. Biroq, savdolarning yo'qligi biznesni tashqi grantlar va yirik hamkorlardan keladigan transhlarga bog'liq qiladi, bu esa aktivning umumiy barqarorligini belgilaydi.

AFMD (Affimed) Sof foyda tarixi 04.07.2022dan 31.05.2025gacha

affimed.com (AFMD) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Affimed N.V.|AFMD - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi AFMD|AFMD - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Affimed|AFMD - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi affimed.com|AFMD - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Affimed|AFMD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Affimed N.V.|AFMD - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar AFMD|AFMD - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Affimed|Shoshilinch likvidlik affimed.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
AFMD - Sof foyda
Kompaniyaning jamlanma tahlili:Affimed
Affimed NV asosiy tovari

Ushbu ko'rsatkich yashirin daromadlar stagnatsiyasini aniqlash uchun choraklik tafovutlarni hisobga olmagan holda, kompaniyaning haqiqiy sof foydasi bo'yicha kunlik bozor konsensusini aks ettiradi. Affimed (AFMD) balans varag'idagi foydalar tahlili moliyaviy pasayishni o'z vaqtida aniqlash imkonini beradi, bu esa Affimed (AFMD) uchun juda muhimdir, chunki global klinik sinovlar o'tkazilayotgan vaqtda dori vositalarining monetizatsiya darajalari logistik uzilishlar va geosiyosiy to'siqlar tufayli sekinlashmoqda.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|PHAR - Sof foyda|NKTR: Sof foyda|Soliqdan keyingi foyda UPB (upstreambio.com)|ZBIO (Zenas Biopharma) - Sof foyda|Immunome Inc - Soliqdan keyingi foyda|Sof foyda GOSS|Sof moliyaviy natija KalVista Corp|Kompaniyaning sof foydasi Septerna Inc SEPN|PVLA - Sof daromad|Savara - Sof foyda|Kompaniyaning sof daromadi Rigel Pharma|ANAB: Sof foyda|Kompaniya foydasi ATXS|ENGN (enGene Holdings Inc.) - Sof foyda|Sof foyda rapt.com|Sof foyda JBIO|ACRS: Soliqdan keyingi foyda|Kompaniyaning sof foydasi Kyverna KYTX|TLSA - Sof daromad|Cabaletta Bio, Inc. - Sof foyda|VTYX (ventyxbio.com) - Kompaniya foydasi|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda AVTX (Avalo Therapeutics, Inc.)|ELDN (Eledon) - Sof foyda|AGEN: Yakuniy foyda|Sof foyda CLYM|Sof foyda zurabio.com (ZURA)|Kompaniyaning sof foydasi aTyr Pharma ATYR|Yakuniy foyda ADAG|IMA - Kompaniyaning sof foydasi|Shattuck Labs, Inc. (STTK) - Sof daromad|EQ: Sof foyda|Connect Biopharma Holdings Limited (CNTB) - Sof foyda|Sof daromad IMUX|ATRA: Yakuniy foyda|Sof foyda IFRX|Sof moliyaviy natija X4 Pharmaceuticals, Inc|Kompaniyaning sof foydasi Adicet Bio, Inc. ACET|CELU - Sof daromad|INMB - Kompaniyaning sof foydasi|Barinthus Biotherapeutics PLC (BRNS) - Sof daromad|KZR (Kezar Life Sciences, Inc) - Sof daromad|SAB Biotherapeutics Inc (SABS) - Sof foyda|Kompaniyaning sof foydasi Akari Therapeutics|Kompaniya foydasi ENLV (Enlivex Therapeutics, Ltd.)|Sof foyda QTTB|GOVX - Kompaniyaning sof daromadi|Sof foyda EDSA (Edesa)|Sof foyda iBio Corporation IBIO|Carisma Tx - Sof foyda|Soliqdan keyingi foyda XTLB|BOLT: Sof foyda|Soliqdan keyingi foyda HCWB (HCW Biologics)|APVO (Aptevo Therapeutics, Inc.) - Sof foyda|aimimmuno.com (AIM) - Sof moliyaviy natija|Kompaniyaning sof foydasi Aditxt (ADTX)|Sof daromad gribio.com GRI|Sof foyda XRTX (XORTX Therapeutics)|Vyome Holdings Inc. (HIND) - Kompaniyaning sof daromadi|Revelation Bio - Sof foyda|INDP (Indaptus Corp) - Kompaniya foydasi|SCNI: Sof foyda|CalciMedica (CALI) - Sof foyda|ALLK (Allakos Inc) - Sof foyda|HOOKIPA - Soliqdan keyingi foyda|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Sof foyda OCEA (Ocean Biomedical, Inc.)|TCBP: Kompaniya foydasi|THRD - Kompaniyaning sof foydasi